Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C12H18N2O5 |
| Molecular Weight | 270.2817 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
InChI
InChIKey=PHUUXVYXSRZACJ-IVZWLZJFSA-N
InChI=1S/C12H18N2O5/c1-6(2)7-4-14(12(18)13-11(7)17)10-3-8(16)9(5-15)19-10/h4,6,8-10,15-16H,3,5H2,1-2H3,(H,13,17,18)/t8-,9+,10+/m0/s1
Epervudine (5-isopropyl-2'-deoxyuridine) is an antiviral compound. The antiviral effect of epervudine on herpes viruses (HSV-1 and HSV-2) is based on the sensitivity of virus DNA to nucleases due to epervudine incorporation into the virus DNA and the resulting change in DNA conformation. Virus selectivity is based on virus induced thymidine kinase activity and on HSV induction of polymerase enzymes catalyzing the incorporation. Epervudine (HEVIZOS) ointment is used to treat herpetic skin infections.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triesters. | 1986-04 |
|
| Differential substrate specificity of DNA polymerase beta and of a DNA polymerase induced by herpes simplex virus type 2 towards thymidine triphosphate analogues. | 1984-03 |
|
| [Antiviral activity of anomeric 5-substituted 2'-deoxyuridines]. | 1979-11-01 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1023
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
SUB06561MIG
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
6439
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
DTXSID50208877
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
512735
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
60136-25-6
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
3G05PH9FAS
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
C76916
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104604
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY | |||
|
100000080469
Created by
admin on Mon Mar 31 18:26:14 GMT 2025 , Edited by admin on Mon Mar 31 18:26:14 GMT 2025
|
PRIMARY |
ACTIVE MOIETY